BioNTech

FDA Vaccine Committee Member Suggests Ending Mass COVID Vaccination

Dr. Paul Offit, a member of the U.S. FDA’s vaccine advisory committee, has written in the New England Journal of Medicine, the world’s top medical journal, calling for an end to the mass vaccination of anyone at low risk from the virus.

CDC Warns of COVID Vax ‘Safety Concern for Ischemic Stroke in People Ages 65’

CDC investigates potential safety concern for ischemic stroke in people ages 65 and older who received Pfizer-BioNTech COVID vaccine.

Penn Biden Center Home Profited From Vaccine Sales, Links to China

Documents from the University of Pennsylvania reveal the fund supporting Biden's think tank, Penn Biden Center, profited from vaccine sales.

Vaccinated More Than Twice as Likely to Be Reinfected with COVID than Unvaccinated: The Lancet

Peer-reviewed medical journal says natural infection provides better protection against reinfection than Pfizer or Moderna vaccine.

COVID Vaccines Have Saved Millions of Lives…in Models

As more and more questions are being asked by more and more scientists, health professionals and journalists, the narrative of “safe and effective” Covid-19 vaccines is crumbling by the day, and scientific truth is slowly beginning to impose itself.

Florida Supreme Court Rules DeSantis Can Investigate COVID Vax Makers

Court says DeSantis can impanel a grand jury to investigate COVID-19 vaccine manufacturers, Pfizer-BioNTech and Moderna, for potential wrongdoing.

FDA Study Links Vax to Blood Clots in Elderly

The Pfizer-BioNTech COVID-19 vaccine may be linked to higher instances of adverse effects in people over 65, including blood clots and heart attacks, according to a study by the FDA, but the agency still maintains that the benefits of the vaccine outweigh the risks of contracting COVID-19.

Pfizer, BioNTech Ask U.S. FDA to Clear Updated COVID-19 Vaccine for Babies and Toddlers

Pfizer and its German partner have asked U.S. regulators to clear their updated COVID-19 vaccine for children as young as 6 months of age, the companies announced on Dec. 5.

Almost No Protection for Elderly From 4th Dose of COVID-19 Vaccine

The relative effectiveness of the fourth dose of a COVID-19 vaccine in the elderly was negligible within months, according to a new study.

Latest news

- Advertisement -spot_img